The Claim
AURKA, CCND1, and RAD51 are upregulated in ovarian cancer tissues and are potential molecular targets of aspartame, as identified through integrated network toxicology and machine learning analysis of multi-omics data.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
AURKA, CCND1, and RAD51 genes show increased activity in ovarian cancer tissues, and computational analysis suggests aspartame may interact with these genes.
See the scientific wording
AURKA, CCND1, and RAD51 are identified as core genes upregulated in ovarian cancer tissues and potentially targeted by aspartame, based on integrated network toxicology and machine learning analysis of multi-omics data.
Aspartame attaches to three specific proteins in ovarian cells, making them more stable and active. One protein forces cells to divide faster, another helps cells move past a checkpoint that normally stops abnormal growth, and the third repairs DNA damage that would otherwise kill the cells. Together, these changes let cancer cells multiply uncontrollably and survive despite damage.
What the research says
1 studyScientists found that aspartame, an artificial sweetener, might make ovarian cancer worse by turning up three specific genes (AURKA, CCND1, RAD51) that help cancer cells grow. They used computer models and lab tests to show this link.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.